Colleagues working across our brain tumour and inflammation themes have been award £700,000 from UK Research and Innovation (UKRI) and The Medical Research Council for their project on Understanding CD8+ T cell responses in NF2-Schwannomatosis-related vestibular schwannoma tumours.
Dr Doug Dyer, part of our stroke and brain inflammation themes, has been awarded a prestigious Wellcome Trust Career Development Award — an exceptional 8-year grant worth over £2M.
The Manchester neuro-oncology service, hosted at Salford Royal Hospital (part of Northern Care Alliance NHS Foundation Trust) in partnership with The Christie NHS Foundation Trust, has again been recognised as a Tessa Jowell Centre of Excellence for the care and treatment of patients with brain and spinal tumours.
Being diagnosed with a brain tumour at the age of 12 had life-changing effects on Emma Hall – but it also inspired her to become a cancer researcher and a Young Ambassador for The Brain Tumour Charity.
The Christie NHS Foundation Trust in Manchester is leading a groundbreaking clinical trial that could transform the treatment of glioblastoma, the most aggressive and deadly form of brain cancer. Known as PORTRAIT, the trial is recruiting newly diagnosed patients to explore whether treatment can begin immediately after diagnosis—before surgery and radiotherapy—using an innovative, non-invasive technology.
The third episode of The Brain Fix podcast series is talking all things Jeff!
In this episode, Professors David Brough and Omar Pathmanaban discuss the Geoffrey Jefferson Brain Research Centre, also known as The Jeff. David and Omar are joined by The Jeff co-directors Professors Stuart Allan and Andrew King who discuss the development, goals and future of our translational neuroscience centre.
We are delighted to announce that the Manchester Epilepsy Research Network (MERN) has joined the Centre as a new epilepsy research theme.
Rare Disease Day is a pivotal time to raise awareness and support for those living with rare conditions such as Neurofibromatosis type 2-related Schwannomatosis (NF2-SWN). Read about the research that NF2BioSolutions funded PhD student Reygn Done is working on…
Lindonlight Collective has awarded $1.97 million to our Chair of Translational Neuro-Oncology Professor Petra Hamerlik for her pioneering work on pediatric low-grade gliomas.
Translation Manchester has announced the Confidence for Translation (C4T) awardees. The call was extremely competitive and we’re proud to celebrate our colleagues at the Centre whose projects were awarded.
Geoffrey Jefferson Brain Research Centre
Clinical Sciences Building
Northern Care Alliance
NHS Foundation Trust
Salford
M6 8FJ
Email: GJBRC@manchester.ac.uk
Recent Comments